PYRIDINEAMIDO DERIVATIVES AS INHIBITORS OF MONOAMINE OXIDASE (MAO-B)
申请人:F. Hoffmann-La Roche AG
公开号:EP1474394A1
公开(公告)日:2004-11-10
US6667327B2
申请人:——
公开号:US6667327B2
公开(公告)日:2003-12-23
[EN] PYRIDINEAMIDO DERIVATIVES AS INHIBITORS OF MONOAMINE OXIDASE (MAO-B)<br/>[FR] DERIVES D'AMIDO-PYRIDINE EN TANT QU'INHIBITEURS DE L'OXYDASE DE MONOAMINE (MAO-B)
申请人:HOFFMANN LA ROCHE
公开号:WO2003066596A1
公开(公告)日:2003-08-14
This invention relates to pyridine amido derivatives of the general formula wherein one of X or Y is -N= and the other one is -CR7=, and R1 to R7 are as defined in the specification. The invention further relates to medicaments containing these compounds, a process for their preparation as well as their use for preparation of medicaments for the treatment or prevention of diseases in which MAO-B inhibitors might be beneficial. These diseases include neurological diseases such as Alzheimer, dementia, Parkinson`s diseases and depression.
Pyridine amido derivatives
申请人:——
公开号:US20030158235A1
公开(公告)日:2003-08-21
Disclosed are pyridine amido derivatives of the formula
1
wherein X, Y, and R
1
to R
6
are as defined herein. These compounds are selective MAO-B inhibitors and are useful in treating diseases such as, for example, Alzheimer's and senile dementia. Also disclosed are pharmaceutical compositions containing such compounds and a method of preparing such compounds.